Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Panbela Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
PBLA is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 0
- −11 vs. Q4 2023
- Shares held
- 0
- −152.0K (−100.0%) vs. Q4 2023
- Total value
- $0
- −$115.8K (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 11
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 11 | $115.8K |
| Q3 2023 | 7 | $71.8K |
| Q2 2023 | 9 | $945.1K |
| Q1 2023 | 20 | $857.7K |
| Q4 2022 | 15 | $34.5K |
| Q3 2022 | 17 | $801.0K |
| Q2 2022 | 13 | $111.0K |
| Q1 2022 | 16 | $1.78M |
| Q4 2021 | 17 | $1.72M |
| Q3 2021 | 18 | $2.41M |
| Q2 2021 | 17 | $3.12M |
| Q1 2021 | 15 | $2.74M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −38,144−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −34,211−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −15,886−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,015−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −12,451−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,689−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −24,513−100.0% | Sold out |